Farrow Jeffrey S
- SEC CIK
- 0001405253
In the past year, 2 open-market sale filings worth $1.32M and no purchases.
Current role at each company
- ACHV Achieve Life Sciences, Inc.Directoras of Jul 29, 2026
- TARS Tarsus Pharmaceuticals, Inc.See Remarksas of Jun 17, 2026
- GBT Global Blood Therapeutics, Inc.Chief Financial Officeras of Oct 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.32M
- 2 filings
- Net
- −$1.32M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Farrow Jeffrey S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TARS Tarsus Pharmaceuticals, Inc.
See Remarks5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 16 | 1 day | Farrow Jeffrey SSee Remarks | SSale | −14.4K | $60.95 | −$877.4K | −20.2%56.8K after | |
| Mar 19, 2026 (view filing) | Mar 17-19 | 2 days | Farrow Jeffrey SSee Remarks | SSale | −6.43K | $68.36 | −$439.6K | −12.9%43.3K after | 3 lots |
| Jun 18, 2025 (view filing) | Jun 17 | 1 day | Farrow Jeffrey SSee Remarks | SSale | −13.6K | $40.42 | −$550.0K | −27.0%36.7K after | |
| Mar 20, 2025 (view filing) | Mar 18-20 | 2 days | Farrow Jeffrey SSee Remarks | SSale | −3.72K | $47.88 | −$178.3K | −14.2%22.4K after | 3 lots |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Farrow Jeffrey SSee Remarks | SSale | −10.4K | $27.47 | −$286.9K | −36.5%18.1K after |
GBT Global Blood Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Farrow Jeffrey SChief Financial Officer | SSale | −31.4K | $68.00 | −$2.14M | −91.1%3.09K after |